Current Assets
AFS and Trading Securities - Unrealized Loss Position (>=12 Months)
Moderna AFS and Trading Securities - Unrealized Loss Position (>=12 Months) decreased by 33.3% to $2M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 81.8%, from $11M to $2M.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2018
Last reportedQ1 2026May 1, 2026
Metric ID:
afs_debt_securities_unrealized_loss_12m_plusHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $21M | $176M | $223M | $289M | $289M | $254M | $147M | $114M | $85M | $33M | $22M | $11M | $7M | $5M | $3M | $2M |
| QoQ Change | — | — | — | +738.1% | +26.7% | +29.6% | +0.0% | -12.1% | -42.1% | -22.4% | -25.4% | -61.2% | -33.3% | -50.0% | -36.4% | -28.6% | -40.0% | -33.3% |
| YoY Change | — | — | — | — | — | — | >999% | +44.3% | -34.1% | -60.6% | -70.6% | -87.0% | -85.0% | -90.4% | -91.8% | -84.8% | -86.4% | -81.8% |
Range$0 – $289M
Avg YoY Growth+45.7%
Median YoY Growth-83.3%
Current Streak11 quarters decline
AFS and Trading Securities - Unrealized Loss Position (>=12 Months) at Other Companies
Frequently Asked Questions
- What is Moderna's afs and trading securities - unrealized loss position (>=12 months)?
- Moderna (MRNA) reported afs and trading securities - unrealized loss position (>=12 months) of $2M in Q1 2026.
- How has Moderna's afs and trading securities - unrealized loss position (>=12 months) changed year-over-year?
- Moderna's afs and trading securities - unrealized loss position (>=12 months) decreased by 81.8% year-over-year, from $11M to $2M.